EUVIMEDEUVIMED entdecken
Open Access

Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms

Eva Armengol, Kasper Nørskov Kragh iD, Tim Tolker-Nielsen iD, Josep M Sierra iD, Doaa Higazy, Oana Ciofu, Miguel Viñas, Niels Høiby

Antimicrobial Agents and Chemotherapy · 18.04.2023 · 67 (4)

DOI: 10.1128/aac.01641-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 18.04.2023. Verfasst von Eva Armengol und 7 weiteren Autor:innen. Beteiligte Einrichtung: Costerton Biofilm Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Colistin, Pseudomonas Infections. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundació la Marató de TV3, UB | Campus Ciències de la Salut de Bellvitge, Universitat de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of multidrug-resistant Pseudomonas aeruginosa infections has urged the need to find new strategies, such as the use of combinations of antibiotics. Among these, the combination of colistin with other antibiotics has been studied.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinPseudomonas InfectionsHumansPseudomonas aeruginosaRifampinAnti-Bacterial AgentsBiofilmsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

biofilmcolistindynamicrifampicinsynergism

Substanzen

ColistinRifampinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Costerton Biofilm Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Laboratory of Molecular Microbiology & Antimicrobials, Department of Pathology & Experimental Therapeutics, Medical School and IDIBELL, University of Barcelona, Hospitalet de Llobregat, Spain.
  • Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.

ORCID-Profile: Kasper Nørskov Kragh, Tim Tolker-Nielsen, Josep M Sierra

Förderung

  • Fundació la Marató de TV3
  • UB | Campus Ciències de la Salut de Bellvitge, Universitat de Barcelona

Zitieren

APA

Armengol, E., Kragh, K. N., Tolker-Nielsen, T., Sierra, J. M., Higazy, D., Ciofu, O., Viñas, M., & Høiby, N. (2023). Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms. Antimicrobial Agents and Chemotherapy, 67(4). https://doi.org/10.1128/aac.01641-22

Vancouver

Armengol E, Kragh KN, Tolker-Nielsen T, Sierra JM, Higazy D, Ciofu O, et al. Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms. Antimicrobial Agents and Chemotherapy. 2023;67(4). doi:10.1128/aac.01641-22

BibTeX
@article{Armengol2023,
  author = {Armengol, Eva and Kragh, Kasper Nørskov and Tolker-Nielsen, Tim and Sierra, Josep M and Higazy, Doaa and Ciofu, Oana and Viñas, Miguel and Høiby, Niels},
  title = {Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  volume = {67},
  number = {4},
  doi = {10.1128/aac.01641-22}
}
Kostenlos starten →